Variants KP.3 ,KP.4.1 grew in prevalence
BC CDC has uploaded more sample data, including 48 from 4/7 - 4/13. Of those, JN.1.11.1.* represented 31.3% (⬆️ 13.4% of 247, 3/31 - 4/6). KP.3, KP.4.1 grew in prevalence (2% → 8.3%; 2% → 12.5%).
Virological characteristics of the SARS-CoV-2 KP.2 variant
ignificant resistance to the monovalent XBB.1.5 vaccine
https://www.biorxiv.org/content/10.1101/2024.04.24.590786v1
The FLiRT variant KP.2, US, 1 in 4 cases
https://covid.cdc.gov/covid-data-tracker/#variant-proportions


